This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Plus, Healthy Minds Project, the Trevor Project, and the University of Montana received big gifts to support mental health services, advocacy, and youth in crisis.

Eli Lilly partnership aims to identify new treatments for ALS based on antibodies from people with very slow disease ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...

Denali Therapeutics Inc. (NASDAQ:DNLI) revealed topline results from an analysis of Regimen G of the Phase 2/3 HEALEY ALS ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

A renowned Israeli TV journalist who lost his ability to speak clearly because of ALS is returning to the air using ...

When a renowned Israeli TV journalist lost his ability to speak clearly because of ALS, he thought his career might be over.

ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in ...

Channel 12 made the surprising announcement that it would bring Nussbaum back on the air in the coming weeks as a commentator ...

NX-210c is under clinical development by Axoltis Pharma and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData, Phase I drugs for Amyotrophic Lateral Sclerosis have an 81% ...